{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T16:57:17Z","timestamp":1769014637816,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.intimp.2022.109542","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T13:20:25Z","timestamp":1670937625000},"page":"109542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Intralesional Bacillus Calmette\u2013Gu\u00e9rin injections and hypo-fractionated radiation synergistically induce systemic antitumor immune responses"],"prefix":"10.1016","volume":"114","author":[{"given":"Hanshan","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuru","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deyi","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linglin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.intimp.2022.109542_b0005","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S1470-2045(15)00222-3","article-title":"Expanding global access to radiotherapy","volume":"16","author":"Atun","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.intimp.2022.109542_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106663","article-title":"Abscopal effect in radioimmunotherapy","volume":"85","author":"Ashrafizadeh","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"8","key":"10.1016\/j.intimp.2022.109542_b0015","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.it.2018.06.001","article-title":"Immunological Mechanisms Responsible for Radiation-Induced Abscopal Effect","volume":"39","author":"Rodr\u00edguez-Ruiz","year":"2018","journal-title":"Trends Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2022.109542_b0020","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000867","article-title":"Tumor-draining lymph node is important for a robust abscopal effect stimulated by radiotherapy","volume":"8","author":"Buchwald","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.intimp.2022.109542_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106761","article-title":"Damage-associated molecular patterns in tumor radiotherapy","volume":"86","author":"Ashrafizadeh","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2022.109542_b0030","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pharmthera.2018.12.002","article-title":"Immune mechanisms mediating abscopal effects in radioimmunotherapy","volume":"196","author":"Rodriguez-Ruiz","year":"2019","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.intimp.2022.109542_b0035","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41590-019-0561-4","article-title":"Immunological impact of cell death signaling driven by radiation on the tumor microenvironment","volume":"21","author":"Rodriguez-Ruiz","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2022.109542_b0040","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3389\/fonc.2018.00612","article-title":"Radiation, Immune Checkpoint Blockade and the Abscopal Effect: A Critical Review on Timing Dose and Fractionation","volume":"8","author":"Buchwald","year":"2018","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.intimp.2022.109542_b0045","article-title":"Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose? J Immunother","volume":"9","author":"Demaria","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.intimp.2022.109542_b0050","doi-asserted-by":"crossref","first-page":"15618","DOI":"10.1038\/ncomms15618","article-title":"DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity","volume":"8","author":"Vanpouille-Box","year":"2017","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.intimp.2022.109542_b0055","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrclinonc.2016.144","article-title":"Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape","volume":"14","author":"Mohme","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109542_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2567.2007.02587.x","article-title":"Cancer immunoediting from immune surveillance to immune escape","volume":"121","author":"Kim","year":"2007","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.intimp.2022.109542_b0065","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nrc.2018.6","article-title":"Using immunotherapy to boost the abscopal effect","volume":"18","author":"Ngwa","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2022.109542_b0070","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.critrevonc.2016.11.001","article-title":"Immuno-oncology: Allying forces of radio- and immuno-therapy to enhance cancer cell killing","volume":"108","author":"Bernier","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"45","key":"10.1016\/j.intimp.2022.109542_b0075","doi-asserted-by":"crossref","first-page":"50734","DOI":"10.1021\/acsami.0c14909","article-title":"Multifunctional Nanoparticles Boost Cancer Immunotherapy Based on Modulating the Immunosuppressive Tumor Microenvironment","volume":"12","author":"Li","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"44","key":"10.1016\/j.intimp.2022.109542_b0080","doi-asserted-by":"crossref","first-page":"e272","DOI":"10.3346\/jkms.2019.34.e272","article-title":"Role of Immunosuppressive Microenvironment in Acquiring Immunotolerance Post-Photothermal Therapy","volume":"34","author":"Cherukula","year":"2019","journal-title":"J. Korean Med. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2022.109542_b0085","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1470-2045(15)70054-9","article-title":"Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial","volume":"16","author":"Rizvi","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.intimp.2022.109542_b0090","doi-asserted-by":"crossref","unstructured":"Turtle, C.J., et al., Immunotherapy of non-Hodgkin's lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells. Sci Transl Med, 2016. 8(355): p. 355ra116.","DOI":"10.1126\/scitranslmed.aaf8621"},{"issue":"3","key":"10.1016\/j.intimp.2022.109542_b0095","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0163-7258(94)90023-X","article-title":"Coley's toxins, tumor necrosis factor and cancer research: a historical perspective","volume":"64","author":"Wiemann","year":"1994","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.intimp.2022.109542_b0100","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00000658-197410000-00029","article-title":"BCG immunotherapy of malignant melanoma: summary of a seven-year experience","volume":"180","author":"Morton","year":"1974","journal-title":"Ann. Surg."},{"issue":"11","key":"10.1016\/j.intimp.2022.109542_b0105","doi-asserted-by":"crossref","DOI":"10.1172\/JCI148291","article-title":"BCG turns 100: its nontraditional uses against viruses, cancer, and immunologic diseases","volume":"131","author":"Singh","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.intimp.2022.109542_b0110","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2567.2012.03575.x","article-title":"Mycobacterium tuberculosis Rv0652 stimulates production of tumour necrosis factor and monocytes chemoattractant protein-1 in macrophages through the Toll-like receptor 4 pathway","volume":"136","author":"Kim","year":"2012","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2022.109542_b0115","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3389\/fimmu.2017.00965","article-title":"Mycobacterium bovis Bacillus Calmette-Gu\u00e9rin Alters Melanoma Microenvironment Favoring Antitumor T Cell Responses and Improving M2 Macrophage Function","volume":"8","author":"Lardone","year":"2017","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109542_b0120","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s40425-019-0537-9","article-title":"Combination treatment with hypofractionated radiotherapy plus IL-2\/anti-IL-2 complexes and its theranostic evaluation","volume":"7","author":"Jing","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.intimp.2022.109542_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105847","article-title":"Targets for improving tumor response to radiotherapy","volume":"76","author":"Mortezaee","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2022.109542_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106807","article-title":"The interactions and communications in tumor resistance to radiotherapy: Therapy perspectives","volume":"87","author":"Ashrafizadeh","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"20","key":"10.1016\/j.intimp.2022.109542_b0135","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.1158\/0008-5472.CAN-16-0549","article-title":"Abscopal Effects of Radiotherapy Are Enhanced by Combined Immunostimulatory mAbs and Are Dependent on CD8 T Cells and Crosspriming","volume":"76","author":"Rodriguez-Ruiz","year":"2016","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.intimp.2022.109542_b0140","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nat. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2022.109542_b0145","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1158\/0008-5472.CAN-14-3511","article-title":"TGF\u03b2 Is a Master Regulator of Radiation Therapy-Induced Antitumor Immunity","volume":"75","author":"Vanpouille-Box","year":"2015","journal-title":"Cancer Res."},{"issue":"23","key":"10.1016\/j.intimp.2022.109542_b0150","doi-asserted-by":"crossref","first-page":"7243","DOI":"10.1158\/1078-0432.CCR-19-1344","article-title":"Cisplatin Facilitates Radiation-Induced Abscopal Effects in Conjunction with PD-1 Checkpoint Blockade Through CXCR3\/CXCL10-Mediated T-cell Recruitment","volume":"25","author":"Luo","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.intimp.2022.109542_b0155","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jaci.2016.12.985","article-title":"Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses","volume":"140","author":"Dowling","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"21","key":"10.1016\/j.intimp.2022.109542_b0160","doi-asserted-by":"crossref","first-page":"6611","DOI":"10.1158\/0008-5472.CAN-11-1801","article-title":"Targeting the immunoregulator SRA\/CD204 potentiates specific dendritic cell vaccine-induced T-cell response and antitumor immunity","volume":"71","author":"Yi","year":"2011","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.intimp.2022.109542_b0165","doi-asserted-by":"crossref","first-page":"926","DOI":"10.7150\/ijbs.57445","article-title":"Macrophage contributes to radiation-induced anti-tumor abscopal effect on transplanted breast cancer by HMGB1\/TNF-\u03b1 signaling factors","volume":"17","author":"Zhu","year":"2021","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2022.109542_b0170","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/s41467-017-01566-5","article-title":"Host STING-dependent MDSC mobilization drives extrinsic radiation resistance","volume":"8","author":"Liang","year":"2017","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.intimp.2022.109542_b0175","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nrd.2018.169","article-title":"Targeting macrophages: therapeutic approaches in cancer","volume":"17","author":"Cassetta","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.intimp.2022.109542_b0180","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13046-018-0860-x","article-title":"Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer","volume":"37","author":"Steenbrugge","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2022.109542_b0185","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.yexmp.2006.06.007","article-title":"Murine mammary carcinoma 4T1 induces a leukemoid reaction with splenomegaly: association with tumor-derived growth factors","volume":"82","author":"DuPre","year":"2007","journal-title":"Exp. Mol. Pathol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109542_b0190","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/s41467-020-15188-x","article-title":"Metastasis-initiating cells induce and exploit a fibroblast niche to fuel malignant colonization of the lungs","volume":"11","author":"Pein","year":"2020","journal-title":"Nat. Commun."},{"issue":"16","key":"10.1016\/j.intimp.2022.109542_b0195","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1158\/0008-5472.CAN-14-0093","article-title":"IL4 receptor ILR4\u03b1 regulates metastatic colonization by mammary tumors through multiple signaling pathways","volume":"74","author":"Venmar","year":"2014","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.intimp.2022.109542_b0200","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1593\/neo.13706","article-title":"The IL-6\/JAK\/Stat3 feed-forward loop drives tumorigenesis and metastasis","volume":"15","author":"Chang","year":"2013","journal-title":"Neoplasia"},{"issue":"7","key":"10.1016\/j.intimp.2022.109542_b0205","doi-asserted-by":"crossref","first-page":"e0181725","DOI":"10.1371\/journal.pone.0181725","article-title":"IL-6 variant is associated with metastasis in breast cancer patients","volume":"12","author":"Abana","year":"2017","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.intimp.2022.109542_b0210","doi-asserted-by":"crossref","DOI":"10.1172\/JCI126089","article-title":"Myeloid cell-derived PROS1 inhibits tumor metastasis by regulating inflammatory and immune responses via IL-10","volume":"131","author":"Maimon","year":"2021","journal-title":"J. Clin. Invest."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692201027X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692201027X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:43:55Z","timestamp":1761587035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757692201027X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":42,"alternative-id":["S156757692201027X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109542","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intralesional Bacillus Calmette\u2013Gu\u00e9rin injections and hypo-fractionated radiation synergistically induce systemic antitumor immune responses","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109542","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109542"}}